# Onity Group Inc.: financial statements, quarterly

ONIT · NYSE · CIK 873860 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/onit.md) · [Financials](/companies/onit/financials.md) · [Filings](/companies/onit/filings.md) · [Insiders](/companies/onit/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/onit/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [256](/filings/0001628280-24-046004.md) | [277 d](/filings/0001628280-26-008625.md) | [239](/filings/0001628280-25-021113.md) | [246](/filings/0001628280-25-037847.md) | [266](/filings/0001628280-25-050223.md) | [225 d](/filings/0001628280-26-008625.md) | [250](/filings/0001628280-26-030753.md) | [247](/filings/0001628280-26-054426.md) | [280](/filings/0001628280-25-050223.md) | [290 d](/filings/0001628280-26-008625.md) | [294](/filings/0001628280-26-030753.md) | [283](/filings/0001628280-26-054426.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [74.3](/filings/0001628280-24-046004.md) | [68.8 d](/filings/0001628280-26-008625.md) | [67.4](/filings/0001628280-25-021113.md) | [73.1](/filings/0001628280-24-034197.md) | [74.2](/filings/0001628280-24-046004.md) | [74.3 d](/filings/0001628280-26-008625.md) | [67.0](/filings/0001628280-25-021113.md) | [75.6](/filings/0001628280-26-054426.md) | [82.9](/filings/0001628280-25-050223.md) | [83.0 d](/filings/0001628280-26-008625.md) | [82.7](/filings/0001628280-26-030753.md) | [103](/filings/0001628280-26-054426.md) |
| Income tax | $m | [1.0](/filings/0001628280-24-046004.md) | [1.8 d](/filings/0001628280-26-008625.md) | [1.7](/filings/0001628280-25-021113.md) | [3.0](/filings/0001628280-25-037847.md) | [6.3](/filings/0001628280-25-050223.md) | [(5.6) d](/filings/0001628280-26-008625.md) | [(13.0)](/filings/0001628280-26-030753.md) | [1.3](/filings/0001628280-26-054426.md) | [4.4](/filings/0001628280-25-050223.md) | [(120) d](/filings/0001628280-26-008625.md) | [0.3](/filings/0001628280-26-030753.md) | [(3.2)](/filings/0001628280-26-054426.md) |
| Net income | $m | [8.5](/filings/0001628280-24-046004.md) | [(47.5) d](/filings/0001628280-26-008625.md) | [30.1](/filings/0001628280-25-021113.md) | [10.5](/filings/0001628280-25-037847.md) | [21.4](/filings/0001628280-25-050223.md) | [(28.1) d](/filings/0001628280-26-008625.md) | [22.1](/filings/0001628280-26-030753.md) | [21.5](/filings/0001628280-26-054426.md) | [18.7](/filings/0001628280-25-050223.md) | [127 d](/filings/0001628280-26-008625.md) | [7.6](/filings/0001628280-26-030753.md) | [(11.9)](/filings/0001628280-26-054426.md) |
| Diluted EPS | $ per share | [1.05](/filings/0001628280-24-046004.md) | not reported | [3.74](/filings/0001628280-25-021113.md) | [1.33](/filings/0001628280-25-037847.md) | [2.65](/filings/0001628280-25-050223.md) | not reported | [2.50](/filings/0001628280-26-030753.md) | [2.40](/filings/0001628280-26-054426.md) | [2.03](/filings/0001628280-25-050223.md) | not reported | [0.74](/filings/0001628280-26-030753.md) | [(1.53)](/filings/0001628280-26-054426.md) |
| Basic EPS | $ per share | [1.10](/filings/0001628280-24-046004.md) | not reported | [3.91](/filings/0001628280-25-021113.md) | [1.34](/filings/0001628280-25-037847.md) | [2.72](/filings/0001628280-25-050223.md) | not reported | [2.68](/filings/0001628280-26-030753.md) | [2.55](/filings/0001628280-26-054426.md) | [2.19](/filings/0001628280-25-050223.md) | not reported | [0.78](/filings/0001628280-26-030753.md) | [(1.53)](/filings/0001628280-26-054426.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001628280-24-046004.md) | [0.2](/filings/0001628280-26-008625.md) | [0.2](/filings/0001628280-25-021113.md) | [0.2](/filings/0001628280-25-037847.md) | [0.2](/filings/0001628280-25-050223.md) | [0.2](/filings/0001628280-26-008625.md) | [0.2](/filings/0001628280-26-030753.md) | [0.2](/filings/0001628280-26-054426.md) | [0.2](/filings/0001628280-25-050223.md) | [0.2](/filings/0001628280-26-008625.md) | [0.2](/filings/0001628280-26-030753.md) | [0.2](/filings/0001628280-26-054426.md) |
| Total assets | $bn | [13.0](/filings/0001628280-23-037390.md) | [12.5](/filings/0001628280-26-008625.md) | [13.1](/filings/0001628280-24-020055.md) | [13.1](/filings/0001628280-24-034197.md) | [13.2](/filings/0001628280-24-046004.md) | [16.4](/filings/0001628280-26-008625.md) | [16.3](/filings/0001628280-25-021113.md) | [16.5](/filings/0001628280-25-037847.md) | [16.1](/filings/0001628280-25-050223.md) | [16.2](/filings/0001628280-26-054426.md) | [17.7](/filings/0001628280-26-030753.md) | [12.4](/filings/0001628280-26-054426.md) |
| Total liabilities | $bn | [12.6](/filings/0001628280-23-037390.md) | [12.1](/filings/0001628280-25-007126.md) | [12.7](/filings/0001628280-24-020055.md) | [12.6](/filings/0001628280-24-034197.md) | [12.8](/filings/0001628280-24-046004.md) | [15.9](/filings/0001628280-26-008625.md) | [15.7](/filings/0001628280-25-021113.md) | [16.0](/filings/0001628280-25-037847.md) | [15.6](/filings/0001628280-25-050223.md) | [15.5](/filings/0001628280-26-054426.md) | [17.1](/filings/0001628280-26-030753.md) | [11.7](/filings/0001628280-26-054426.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.4](/filings/0001628280-24-046004.md) | [0.4](/filings/0001628280-25-007126.md) | [0.4](/filings/0001628280-25-037847.md) | [0.4](/filings/0001628280-25-050223.md) | [0.5](/filings/0001628280-25-050223.md) | [0.4](/filings/0001628280-26-008625.md) | [0.5](/filings/0001628280-26-054426.md) | [0.5](/filings/0001628280-26-054426.md) | [0.5](/filings/0001628280-25-050223.md) | [0.6](/filings/0001628280-26-008625.md) | [0.6](/filings/0001628280-26-054426.md) | [0.6](/filings/0001628280-26-054426.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [377 d](/filings/0001628280-24-046004.md) | [282 d](/filings/0001628280-26-008625.md) | [(297)](/filings/0001628280-25-021113.md) | [(77.9) d](/filings/0001628280-25-037847.md) | [19.2 d](/filings/0001628280-25-050223.md) | [(218) d](/filings/0001628280-26-008625.md) | [(148)](/filings/0001628280-26-030753.md) | [(599) d](/filings/0001628280-26-054426.md) | [230 d](/filings/0001628280-25-050223.md) | [(231) d](/filings/0001628280-26-008625.md) | [(1,590)](/filings/0001628280-26-030753.md) | [(516) d](/filings/0001628280-26-054426.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001628280-24-046004.md) | [0.0 d](/filings/0001628280-26-008625.md) | [0.1](/filings/0001628280-25-021113.md) | [0.1 d](/filings/0001628280-25-037847.md) | [0.1 d](/filings/0001628280-25-050223.md) | [0.5 d](/filings/0001628280-26-008625.md) | [0.3](/filings/0001628280-26-030753.md) | [0.0 d](/filings/0001628280-26-054426.md) | [0.7 d](/filings/0001628280-25-050223.md) | [1.9 d](/filings/0001628280-26-008625.md) | [0.1](/filings/0001628280-26-030753.md) | [0.8 d](/filings/0001628280-26-054426.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-23-037390.md) | [0.0 d](/filings/0001628280-24-007261.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-030753.md) | [0.0 d](/filings/0001628280-26-054426.md) | not reported | not reported | [6.1](/filings/0001628280-26-030753.md) | [5.9 d](/filings/0001628280-26-054426.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,867](/filings/0001628280-23-037390.md) | [7,534](/filings/0001628280-24-020055.md) | [7,920](/filings/0001628280-24-034197.md) | [8,060](/filings/0001628280-24-046004.md) | [8,046](/filings/0001628280-25-021113.md) | [7,919](/filings/0001628280-25-037847.md) | [8,055](/filings/0001628280-25-050223.md) | [8,437](/filings/0001628280-26-030753.md) | [8,535](/filings/0001628280-26-054426.md) | [8,718](/filings/0001628280-25-050223.md) | [8,982](/filings/0001628280-26-030753.md) | [8,447](/filings/0001628280-26-054426.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,354,520 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054426.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.